Skip to Content

Morphine / naltrexone Pregnancy and Breastfeeding Warnings

Morphine / naltrexone is also known as: Embeda

Morphine / naltrexone Pregnancy Warnings

This drug should be used during pregnancy only if the benefit clearly outweighs the risk to the fetus. US FDA pregnancy category: C Comments: -Prolonged use of opioids during pregnancy can result in physical dependence in the neonate; women should be advised of the risk of neonatal abstinence syndrome and ensure that appropriate treatment will be available. -Long-acting opioids should not be used during and immediately prior to labor, when short acting analgesics or other analgesic techniques are more appropriate.

Animal studies have shown that morphine exposure during pregnancy is associated with growth reduction and behavioral abnormalities. Chronic morphine exposure of fetal animals showed altered reflex and motor skill development, mild withdrawal, and altered responsiveness to morphine persisting into adulthood. There are no adequate and well-controlled studies in pregnant women. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Morphine / naltrexone Breastfeeding Warnings

Morphine is excreted into breast milk with milk to plasma ratios of approximately 2.5 to 1. Newborn infants appear to be particularly sensitive to even small doses of oral narcotics with drowsiness, central nervous system depression, and even death having been reported. Naltrexone is minimally excreted into breast milk.

A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Yes (morphine); Yes (naltrexone) Comments: Breastfed infants should be closely monitored; withdrawal symptoms can occur when maternal administration of morphine is stopped.

See references

References for pregnancy information

  1. "Product Information. Embeda (morphine-naltrexone)." King Pharmaceuticals Inc, Bristol, TN.

References for breastfeeding information

  1. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL:" ([cited 2013 -]):
  2. "Product Information. Embeda (morphine-naltrexone)." King Pharmaceuticals Inc, Bristol, TN.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.